ORIC Pharmaceuticals, Inc. (ORIC)
ORIC Stock Price Chart
Explore ORIC Pharmaceuticals, Inc. interactive price chart. Choose custom timeframes to analyze ORIC price movements and trends.
ORIC Company Profile
Discover essential business fundamentals and corporate details for ORIC Pharmaceuticals, Inc. (ORIC) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
24 Apr 2020
Employees
122.00
Website
https://www.oricpharma.comCEO
Jacob M. Chacko
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment regimens; ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 for prostate cancer; and ORIC-114, a brain penetrant orally bioavailable irreversible inhibitor designed to selectively target epidermal growth factor receptor and human epidermal growth factor receptor 2 with high potency towards exon 20 insertion mutations. The company is also developing multiple discovery stage precision medicines targeting other cancer resistance mechanisms. It has a license and collaboration agreement with Voronoi Inc.; and a license agreement with Mirati Therapeutics, Inc. The company was incorporated in 2014 and is headquartered in South San Francisco, California.
ORIC Financial Timeline
Browse a chronological timeline of ORIC Pharmaceuticals, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 4 May 2026
Upcoming earnings on 16 Feb 2026
Upcoming earnings on 11 Nov 2025
EPS estimate is -$0.43.
Earnings released on 12 Aug 2025
EPS came in at -$0.47 falling short of the estimated -$0.46 by -2.17%.
Earnings released on 5 May 2025
EPS came in at -$0.42 surpassing the estimated -$0.51 by +17.65%.
Earnings released on 18 Feb 2025
EPS came in at -$0.51 surpassing the estimated -$0.52 by +1.92%, while revenue for the quarter reached $533.00K .
Earnings released on 12 Nov 2024
EPS came in at -$0.49 falling short of the estimated -$0.48 by -2.08%.
Earnings released on 12 Aug 2024
EPS came in at -$0.45 falling short of the estimated -$0.42 by -7.14%.
Earnings released on 6 May 2024
EPS came in at -$0.37 surpassing the estimated -$0.44 by +15.91%.
Earnings released on 11 Mar 2024
EPS came in at -$0.49 matching the estimated -$0.49, while revenue for the quarter reached $1.54M .
Earnings released on 6 Nov 2023
EPS came in at -$0.44 surpassing the estimated -$0.46 by +4.35%.
Earnings released on 10 Aug 2023
EPS came in at -$0.50 surpassing the estimated -$0.58 by +13.79%.
Earnings released on 8 May 2023
EPS came in at -$0.53 surpassing the estimated -$0.54 by +1.85%.
Earnings released on 16 Mar 2023
EPS came in at -$0.52 surpassing the estimated -$0.56 by +7.14%.
Earnings released on 7 Nov 2022
EPS came in at -$0.63 falling short of the estimated -$0.55 by -14.55%.
Earnings released on 11 Aug 2022
EPS came in at -$0.51 surpassing the estimated -$0.60 by +15.00%.
Earnings released on 9 May 2022
EPS came in at -$0.59 falling short of the estimated -$0.57 by -3.51%.
Earnings released on 21 Mar 2022
EPS came in at -$0.58 surpassing the estimated -$0.61 by +4.92%.
Earnings released on 8 Nov 2021
EPS came in at -$0.47 surpassing the estimated -$0.58 by +18.97%.
Earnings released on 10 Aug 2021
EPS came in at -$0.57 falling short of the estimated -$0.50 by -14.00%.
Earnings released on 6 May 2021
EPS came in at -$0.45 surpassing the estimated -$0.48 by +6.25%.
Earnings released on 23 Mar 2021
EPS came in at -$0.84 falling short of the estimated -$0.50 by -68.00%.
Earnings released on 5 Nov 2020
EPS came in at -$0.84 falling short of the estimated -$0.39 by -115.38%.
ORIC Stock Performance
Access detailed ORIC performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.